Neurocrine Biosciences, Inc.
600 articles about Neurocrine Biosciences, Inc.
-
Neurocrine Biosciences, Inc. Reports Fourth Quarter And Year-End 2006 Results
2/2/2007
-
Neurocrine Biosciences, Inc. Receives Award From The Michael J. Fox Foundation For A2A Research In Parkinson's Disease
1/24/2007
-
The Day In Review: Coley Pharmaceutical Group Drops After Ending Hepatitis C Program
1/23/2007
-
Neurocrine Biosciences, Inc. Announces Plans To Resubmit NDA for Indiplon Capsules In Q2 2007
1/23/2007
-
Neurocrine Biosciences, Inc. Announces Conference Call And Webcast To Present Year End And Fourth Quarter 2006 Financial Results
1/23/2007
-
The Day In Review: Seattle Genetics, Inc. Sells Cancer Drug To Genentech, Inc.
1/8/2007
-
Neurocrine Biosciences, Inc. Announces Positive Results From Second Phase II Study With Its Orally Active GnRH Receptor Antagonist In Endometriosis
1/8/2007
-
Neurocrine Biosciences, Inc. Announces Initiation Of Phase II Clinical Trials With CRF1 Antagonist For Anxiety And IBS
12/20/2006
-
Neurocrine Biosciences, Inc. Announces Conference Call And Webcast To Present Third Quarter 2006 Financial Results
10/12/2006
-
Neurocrine Biosciences, Inc. Announces Employee Stock Option Exchange Tender Offer Accepted
9/28/2006
-
Neurocrine Biosciences, Inc. To Present At The UBS Warburg Global Life Sciences Conference
9/21/2006
-
Neurocrine Biosciences, Inc. Announces Changes In Executive Lineup; Chief Financial Officer Decides To Retire
9/20/2006
-
The Day In Review: Valeant Pharmaceuticals International Rises Despite Mixed Trial Results
9/12/2006
-
Neurocrine Biosciences, Inc. To Present At The Bear Stearns Annual Health Care Conference
9/12/2006
-
Neurocrine Biosciences, Inc. Announces Results From Follow-Up Phase II Study With Its Orally Active GnRH Receptor Antagonist In Endometriosis
9/12/2006
-
The Day In Review: Genasense Gets Negative FDA Report
9/5/2006
-
FDA Reports Results Of Neurocrine Biosciences, Inc. End-Of-Review Meeting On Indiplon Capsules NDA; FDA Seeks More Details
9/5/2006
-
Neurocrine Biosciences, Inc. Announces Employee Stock Option Exchange Program
8/28/2006
-
The Day In Review: Januvia From Merck & Co., Inc. Gets First Approval
8/8/2006
-
Neurocrine Biosciences, Inc. Announces San Diego Campus Restructuring; To Cut 100 Jobs
8/8/2006